675 related articles for article (PubMed ID: 19877093)
21. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
[TBL] [Abstract][Full Text] [Related]
22. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.
De Vera MA; Choi H; Abrahamowicz M; Kopec J; Lacaille D
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):809-16. PubMed ID: 22467274
[TBL] [Abstract][Full Text] [Related]
23. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
24. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.
Panoulas VF; Milionis HJ; Douglas KM; Nightingale P; Kita MD; Klocke R; Elisaf MS; Kitas GD
Rheumatology (Oxford); 2007 Sep; 46(9):1466-70. PubMed ID: 17644822
[TBL] [Abstract][Full Text] [Related]
25. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
26. The widening mortality gap between rheumatoid arthritis patients and the general population.
Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
[TBL] [Abstract][Full Text] [Related]
27. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
28. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample.
De Pablo P; Dietrich T; Karlson EW
Arthritis Rheum; 2007 Aug; 57(6):953-62. PubMed ID: 17665477
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
[TBL] [Abstract][Full Text] [Related]
30. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.
Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Sep; 46(9):2287-93. PubMed ID: 12355475
[TBL] [Abstract][Full Text] [Related]
31. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
32. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
33. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
[TBL] [Abstract][Full Text] [Related]
34. Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis.
Mattey DL; Glossop JR; Nixon NB; Dawes PT
Arthritis Rheum; 2007 Dec; 56(12):3940-8. PubMed ID: 18050238
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk factors in women with and without rheumatoid arthritis.
Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
[TBL] [Abstract][Full Text] [Related]
36. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
Petersson U; Ostgren CJ; Brudin L; Nilsson PM
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
[TBL] [Abstract][Full Text] [Related]
37. Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric type II diabetes.
Gimeno-Orna JA; Lou-Arnal LM; Boned-Juliani B; Molinero-Herguedas E
Diabetes Res Clin Pract; 2004 Jun; 64(3):191-9. PubMed ID: 15126007
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
39. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
Book C; Saxne T; Jacobsson LT
J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
[TBL] [Abstract][Full Text] [Related]
40. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.
Scherrer JF; Virgo KS; Zeringue A; Bucholz KK; Jacob T; Johnson RG; True WR; Carney RM; Freedland KE; Xian H; Caplan L; McDonald J; Eisen SA
Gen Hosp Psychiatry; 2009; 31(4):353-9. PubMed ID: 19555796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
